The investigation of prophylactic clip hemorrhage control for colorectal cold snare polypectomy in patients taking anti-thrombotic drugs. - PERCOLD study

Okimoto Kenichiro0 个研究点目标入组 574 人开始时间: 2023年5月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. taking anti-thrombotic medication
•2. 20 years of age or older at the time of consent (regardless of gender)
•3. consent to participate in this study
•4. have a preoperative suspected adenoma (including SSL) with endoscopic diameter < 10 mm and an indication for CSP (up to 10 lesions per patient)
•5. more than 4 weeks interval from endoscopic polypectomy (CSP, EMR, ESD, etc.) in the colon
•6. able to respond to antithrombotic drugs according to the guidelines.

•1. gastrointestinal polyposis (e.g. familial adenomatous polyposis of the colon [FAP], but Lynch syndrome [HNPCC] is not excluded)
•2. inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease)
•3. lesions with obvious fibrosis (including post-treatment recurrence)
•4. tumors with preoperative suspicion of cancer
•5. lesions with stoke
•6. patients undergoing endoscopic treatment other than CSP at the same time
•7. pregnant
•8. patients on dialysis or with cirrhosis of the liver
•9. patients with American Society of Anesthesiologists Class III or higher (patients with severe systemic diseases)
•10. platelet and coagulation factor dysfunction (e.g., hemophilia)
•11. patients taking more than 3 antithrombotic drugs
•12. other patients deemed ineligible by the physician in charge

发起方

Okimoto Kenichiro